IIHS has given 49 cars its Top Safety Pick+ award while 41 models earned one without the plus. Hyundai scored more awards than any other carmaker.... Read more.

SURAT: The Gujarat Pollution Control Board (GPCB) on Wednesday issued total closure notice to United Phosphorus Limited (UPL)�s Jhagadia plant, a day .... Read more.

Tokyo 2020 President said Thursday that "it is very important to give priority to safety as a countermeasure against COVID-19 infections" ahead of the Olympic Torch Relay on Thursday.... Read more.

How is Covid vaccine safety ensured? - Daijiworld.com... Read more.

The letter cited other recent engine failures, including a December failure in Japan and the 2018 Southwest Airlines Flight 1380 failure of a CFM56-7B turbofan engine that led to the death of passenger after shrapnel shattered a window... Read more.

Devon Cantwell and Rebecca Hardenbrook: Utah bill would help ensure the safety of college students... Read more.

TERRE HAUTE, Ind. (WTWO/WAWV) � According to a study conducted by Purdue University, Indiana has seen an increase in grain bin entrapments in recent years. Purdue University says in 2019, there were 38 grain bin entrapments, a 26% increase from 2018. For Grain Bin Safety Week, Feb. 21-27, one local woman has been advocating for more […]... Read more.

Three studies have been published describing water and foodborne outbreaks in India and the Philippines. The articles, in a supplement of the... Read more.

Runners are to refrain from dining with people in the two weeks before the event and to keep a daily record of their temperatures.. Read more at straitstimes.com.... Read more.

Facebook recently launched a 'family-serye' to promote online safety among its users in the Philippines. ... Read more.

7 June 2021... Read more.

Two Downriver businesses were cited for COVID-19 workplace safety violations by the Michigan Occupational Safety and Health Administration after inspections.... Read more.

Community First Medical Center in Portage Park is contesting a citation and $13,494 penalty issued by the federal Occupational Safety and Health Administration in December related to COVID-19 safety.... Read more.

By Collin Breaux A local teachers union alleges there has been inadequate contact tracing and delayed notifications of positive COVID-19 cases on campuses.... Read more.

As COVID numbers drop, local event organizers hope they get the chance to bring live entertainment to the Miami Valley.... Read more.

PETALING JAYA: National top women�s pair Chow Mei Kuan-Lee Meng Yean were supposed to make their second All-England appearance from March 17-21.... Read more.

Metro Detroit bus systems to resume fare collection, add COVID safety measures... Read more.

New Traffic Safety Campaign Aimed At Minimizing Accidents... Read more.

An area fire department just outside Region 8 asks people to be careful, and that safety is especially important for operating appliances around the home.... Read more.

-IGNITE DMD Principal Investigator, Dr. Barry Byrne, to present efficacy and safety data from the ongoing IGNITE DMD trial on Thursday, March 18- -Company to host external key opinion leaders at a symposium to discuss Real World Outcomes Measures in Duchenne Muscular Dystrophy during the conference- -Company to host conference call to discuss the interim one-year clinical trial data and fourth quarter and full year 2020 financial results on Monday, March 15 at 4:30 PM ET- CAMBRIDGE, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced that one-year efficacy and safety data from the ongoing IGNITE-DMD Phase I/II study of SGT-001 microdystrophin gene therapy in patients with Duchenne muscular dystrophy (Duchenne) will be presented at the 2021 MDA Virtual Clinical & Scientific Conference. Barry Byrne, MD, PhD, Associate Chair of Pediatrics and Director of the Powell Gene Therapy Center at the University of Florida, and IGNITE DMD principal investigator, will present the data during a virtual oral session on Thursday, March 18, 2021 at 4 PM ET. Details of the MDA presentation: Session Title: IGNITE-DMD: Phase I/II Ascending Dose Study of Single IV Infusion of SGT-001 Microdystrophin Gene Therapy for DMD: One Year Efficacy and Safety Results Session Date: Thursday, March 18, 2021 4 PM ET Registration: The public must be registered to view live-broadcast sessions, on-demand videos, virtual networking sessions, exhibits and poster sessions. To register, visit: https://mdavirtualconference.org/en/registration Symposium with Key Opinion LeadersAlso, on March 18, Solid Biosciences will sponsor a symposium, “Real World Outcome Measures in Duchenne Muscular Dystrophy: Current and Novel Assessments of Meaningful Patient Benefit” at 12 PM ET. The symposium will feature: Valeria Ricotti, MD, Co-Founder, Executive Vice-President & Chief Medical Officer at DiNAQOR AGChad R. Heatwole, MD, MS-CI, Professor of Neurology, Associate Director of the Center for Health + Technology (CHeT) and CHeT Outcomes Division Director at the University of Rochester Medical CenterCraig M. McDonald, MD, Professor and Chair of the Department of Physical Medicine and Rehabilitation at the University of California, Davis Registration: The public must be registered to view live-broadcast sessions, on-demand videos, virtual networking sessions, exhibits and poster sessions. Company Conference CallSolid Biosciences’ management will host a conference call beginning at 4:30 PM ET on Monday, March 15, 2021 to discuss the IGNITE DMD data that will be presented at the MDA Conference, the Company’s fourth quarter and full year 2020 financial results and recent business developments. A live webcast of the call will be available on the Company's website at www.solidbio.com under the “News & Events” tab in the Investor Relations section, or by clicking here. Participants may also access the call, by dialing 866-763-0341 for domestic callers or 703-871-3818 for international callers, referencing conference ID# 1669808. The archived webcast will be available in the “News and Events” section of the Company's website. About Solid BiosciencesSolid Biosciences is a life sciences company focused on advancing transformative treatments to improve the lives of patients living with Duchenne. Disease-focused and founded by a family directly impacted by Duchenne, our mandate is simple yet comprehensive – work to address the disease at its core by correcting the underlying mutation that causes Duchenne with our lead gene therapy candidate, SGT-001. For more information, please visit www.solidbio.com. Investor Contact:David CareyFINN [email protected] Media Contact:Erich SandovalFINN [email protected]... Read more.

Although the reasons for snowmobile crashes can vary drastically from case-to-case, there have been several high-profile incidents in Minnesota and Wisconsin.... Read more.